Adarx Pharmaceuticals, Inc. · NASDAQ:ADRX

ORBIMED ADVISORS LLC reported a 14.00% stake in Adarx Pharmaceuticals, Inc. (Schedule 13D)

Event Sep 28, 2026 · Filed Oct 2, 2026

ORBIMED ADVISORS LLC reported a 14.00% stake in Adarx Pharmaceuticals, Inc., 14,913,764 shares, with active intent on Sep 28, 2026. Filed Oct 2, 2026 (Schedule 13D).

Stake
14.00%
Shares
14,913,764
Intent
Active
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC14.00%14,913,764
ORBIMED CAPITAL GP VII LLC13.40%14,325,529
ORBIMED ADVISORS ISRAEL II LTD8.70%9,292,025
ORBIMED ISRAEL GP II, L.P.8.70%9,292,025
OrbiMed Genesis GP LLC0.60%588,235

Source

View original at SEC

Related